ImportRefusal LogoImportRefusal

SHANDONG BLUE SAIL INNOVATION CO LTD

⚠️ Moderate Risk

FEI: 3004150701 • Weifang, Shandong • CHINA

FEI

FEI Number

3004150701

📍

Location

Weifang, Shandong

🇨🇳

Country

CHINA
🏢

Address

Mi He East Rd, Linquxian, Weifang, Shandong, China

Moderate Risk

FDA Import Risk Assessment

38.7
LowModerateHighCritical

This firm has a moderate history of FDA import refusals. Some attention may be warranted.

Statistics

9
Total Refusals
5
Unique Violations
3/2/2011
Latest Refusal
6/28/2005
Earliest Refusal

Score Breakdown

Violation Severity
65.0×40%
Refusal Volume
37.0×30%
Recency
0.0×20%
Frequency
15.8×10%
How is this score calculated?

Proprietary Algorithm

  • 40% Violation Severity — AI-assessed (1-10)
  • 30% Refusal Volume — Logarithmic scale
  • 20% Recency — Decays over 5 years
  • 10% Frequency — Refusals per year

© ImportRefusal.com Original Analysis

Violation Summary

5088×

NO 510(K)

The article is subject to refusal of admission pursuant to Section 801(a)(3) in that it is a post 1976 device for which a Section 510(k)application does not appear to have been determined substantially equivalent or otherwise filed.

1181×

NOT LISTED

It appears the drug or device is not included in a list required by Section 510(j), or a notice or other information respecting it was not provided as required by section 510(j) or 510(k).

161×

DIRECTIONS

The article is subject to refusal of admission pursuant to section 801(a)(3) in that it is a device whose label appears to not bear adequate directions for use.

3411×

REGISTERED

It appears the device is subject to listing under 510(j) and the initial distributor has not registered as required by 21 CFR 807.20 (a)(5).

4771×

HOLES

The quality of the article falls below that which it purports or is represented to possess, in that the devices contain defects/holes.

Refusal History

DateProductViolationsDivision
3/2/2011
80LYYGLOVE, PATIENT EXAMINATION, LATEX
118NOT LISTED
16DIRECTIONS
341REGISTERED
508NO 510(K)
Los Angeles District Office (LOS-DO)
5/8/2009
80LYZGLOVE, PATIENT EXAMINATION, VINYL
508NO 510(K)
Seattle District Office (SEA-DO)
5/8/2009
80LYZGLOVE, PATIENT EXAMINATION, VINYL
508NO 510(K)
Seattle District Office (SEA-DO)
5/8/2009
80LYZGLOVE, PATIENT EXAMINATION, VINYL
508NO 510(K)
Seattle District Office (SEA-DO)
5/8/2009
80LYZGLOVE, PATIENT EXAMINATION, VINYL
508NO 510(K)
Seattle District Office (SEA-DO)
5/8/2009
80LYZGLOVE, PATIENT EXAMINATION, VINYL
508NO 510(K)
Seattle District Office (SEA-DO)
5/8/2009
80LYZGLOVE, PATIENT EXAMINATION, VINYL
508NO 510(K)
Seattle District Office (SEA-DO)
4/30/2009
80LYZGLOVE, PATIENT EXAMINATION, VINYL
508NO 510(K)
Seattle District Office (SEA-DO)
6/28/2005
80LYZGLOVE, PATIENT EXAMINATION, VINYL
477HOLES
Southwest Import District Office (SWI-DO)

Frequently Asked Questions

What is SHANDONG BLUE SAIL INNOVATION CO LTD's FDA import refusal history?

SHANDONG BLUE SAIL INNOVATION CO LTD (FEI: 3004150701) has 9 FDA import refusal record(s) in our database, spanning from 6/28/2005 to 3/2/2011.

What is an FEI number?

FEI stands for Firm Establishment Identifier. It's a unique number assigned by the FDA to identify establishments that manufacture, process, pack, or hold food, drugs, medical devices, or other FDA-regulated products. SHANDONG BLUE SAIL INNOVATION CO LTD's FEI number is 3004150701.

What types of violations has SHANDONG BLUE SAIL INNOVATION CO LTD received?

SHANDONG BLUE SAIL INNOVATION CO LTD has been cited for 5 different violation type(s). Common FDA violations include adulteration (unsafe or unsanitary products), misbranding (incorrect or misleading labels), and regulatory non-compliance.

Where does this information about SHANDONG BLUE SAIL INNOVATION CO LTD come from?

All FDA import refusal data for SHANDONG BLUE SAIL INNOVATION CO LTD is sourced from the official FDA Data Dashboard (datadashboard.fda.gov), a public government database maintained by the U.S. Food and Drug Administration.

Data sourced from the FDA Data Dashboard, a public database maintained by the U.S. Food and Drug Administration.